Core Phase III clinical trial program complete; BIL showed consistent HbA1c superiority against comparators Lilly expects U.S. and European regulatory...
Read moreAbbVie Inc. could pay for a pharmaceutical firm in Massachusetts more than $800 million in a collaboration on a potential...
Read moreKnight Therapeutics, a leading Canadian specialty pharmaceutical company, has entered into an agreement of purchase of assets with Orphan Canada...
Read moreTasly Holding Group, a leading pharmaceutical company in China, officially launched its North American operations in the state of Maryland...
Read moreAntares Pharma, Inc. today announced that Eamonn P. Hobbs, President and Chief Executive Officer and Robert F. Apple, Chief Financial...
Read moreThe board of directors of Luye Pharma Group Ltd., announced yesterday that the Company had entered into an agreement to...
Read moreThe board of directors of Luye Pharma Group Ltd., announced yesterday that the Company had entered into an agreement to...
Read moreCleveXel Pharma today announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company...
Read more
Researchers at UCC have developed a microneedle-based patch that results in increased vaccine-induced protection against malaria infection using lower doses...
Read moreLiverpool biotech firm Redx Pharma has signed a “transformational” multi-million pound deal with global pharmaceutical giant AstraZeneca to develop new...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
